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Abstract (word count 239) 
Background and aims: Cigarette smoking is associated with severe mental illness including 
schizophrenia and bipolar disorder, and with morbidity and mortality, but the association 
withanorexia (AN), bulimia nervosa (BN) and Binge Eating Disorder (BED), is unclear. This 
meta-analysis compared the odds of smoking in Eating Disorders (ED) (ED= AN or BN or BED) 
versus healthy controls (HC) and calculated the prevalence of smokers in people with ED. 
Methods: Three independent authors searched PubMed,MEDLINE and Scopus from 
database inceptionuntil 12/31/2015 for studies reporting data on life-time or current 
smoking prevalence in BED, BN, and AN, with or without control group. Meta-analyses were 
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undertaken, calculating odds ratios (ORs) of life-time smoking in BED, BN, AN vs HCs, or 
prevalence of smoking in BED, BN, AN with 95% confidence intervals (CI). 
Results: Thirty-one studies (ED=8,517, controls=68,335) were meta-analyzed. Compared 
with HCs, there were significantly more smokers among people with BN (life-time OR=2.165) 
and BED (life-time OR=1.792) but not AN (life-time OR=0.927). BED was associated with 
smoking the most (life-time prevalence=47.7%) followed by BN (life-time prevalence=39.4%) 
and AN (life-time prevalence=30.8%). In BN, life-time smoking prevalence was highest in 
Europe. In AN, higher age moderated both life-time and current smoking prevalence, and 
body mass index moderated higher life-time smoking prevalence. In BN, female sex 
moderated higher life-time smoking prevalence. 
Conclusions: People with binge eating disorder and bulimia nervosa are significantly more 
likely to be life-time smokers than healthy controls, which is not the case for anorexia 
nervosa.  
 
Keywords: smoking; anorexia nervosa; bulimia nervosa; binge eating disorder; eating disorders, 
meta-analysis, moderators.  
Introduction 
People with eating disorders often have comorbid psychiatric and substance use disorders 
(1,2).In particular, abuse of alcohol and illicit drugs has been highly associated with anorexia (AN), 
bulimia nervosa (BN) and Binge Eating Disorder (BED) (3,4);however, very little is known about 
cigarette smoking rates.  
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In mental illness smoking is highly prevalent, with values even higher than 50% when 
considering a life-time diagnosis of mental illness(5), and in the general population, smoking is a 
leading cause of premature mortality (6); there are a number of pertinent effects of cigarette 
smoking that could be particularly deleterious among people with ED, as both AN and BN typically 
have an onset in the teenage years(7), but surprisingly smoking prevalence in BED, BN and AN has 
not been considered in previous reviews.(5) Also, smoking is a relevant issue to anorexia (AN) and 
bulimia nervosa (BN), since smoking is a risk factor for higher oxidative stress and inflammatory 
levels (8,9), as well as for osteoporosis and fractures, which are often observed in AN (10). 
Furthermore, concomitant consequences of high levels of alcohol, nutritional deficiency and acidic 
damage due to self-induced vomiting already put people with AN and BN at higher risk of 
esophageal cancer(11), and smoking is an additional, established risk factor for esophageal 
cancer.(12) Moreover, pulmonary consequences of smoking in AN are well known; in a malnourished 
population often with associated emphysema-like changes, cigarette use could induce even worse 
damage, potentially leading to high lung cancer risk (13,14). Also, BED is often in comorbidity with 
obesity and metabolic syndrome, and smoking would further add to the increased cardiovascular 
risk profile.(15,16)   
The relationship between smoking and ED appears to be complex.  Smoking could be used as 
a weight-control strategy by women affected by ED(17). There appears to be a longstanding belief 
that nicotine suppresses appetite, and smoking has been shown to increase resting metabolic rate 
(18), which is why smoking is used for weight control(19,20). In individuals with ED, the perceived 
benefits of nicotine for weight-control and temporary stress reduction may outweigh any concerns 
about the long-term harms of smoking. Women’s concerns about body shape and weight, and their 
belief that smoking helps to control appetite, have indeed been considered as factors which may 
influence initiation of smoking(21) and relapse after periods of abstinence(22,23). Finally, in the 
general population, smoking cessation has been associated with a mean increase of 4-5 kg in body 
weight after 12 months of abstinence, with a wide variation in weight change; 16% of quitters lose 
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weight and 13% gain more than 10 kg(16). Determining the prevalence of smoking among people 
with ED, and comparing it with the general population is an important public health issue; a meta-
analytic approach is a reliable method to correctly estimate the prevalence of smokers in patients 
with ED.   
We conducted the first meta-analysis investigating the prevalence of smoking among people 
with ED versus healthy controls (HCs). In particular, we compared (i) smoking rates in BED, BN, and 
AN vs HCs, calculating OR (ii) calculated the prevalence and moderators of smoking prevalence in 
each ED.  
 
Methods 
 
This systematic review adhered to the MOOSE guidelines (26) and PRISMA statement (27). 
 
Inclusion criteria 
Eligible studies had to meet the following criteria:  (1) included participants of any age with a 
primary diagnosis of any ED (i.e., AN, BN, BED, eating disorder not otherwise specified (EDNOS) 
based on established criteria (e.g., DSM-III, DSM-IV, or ICD-10), (2) reported data about either 
current and/or life-time smoking status (through self-report, questionnaire or medical notes), (3) 
published in a peer reviewed journal, (4) had a control group for OR calculation, or either had or did 
not have a control group for prevalence calculation, and (5) was written in English. When we 
encountered mixed samples of ED, where it was not possible to stratify the results, the study was 
excluded due to significant clinical differences across ED that were expected to affect the risk of 
smoking .  
 
Information sources and searches 
Three authors (BS, NV, MS) independently searched PubMed, MEDLINE and Scopus from 
database inception until December, 31st 2015, using the following search strategy: ("eating disorder" 
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OR "anorexia" OR "bulimia" OR "binge eating disorders") AND ("smoke" OR "smoking" OR "cigarette" 
OR “tobacco” OR “nicotine”). We also checked the reference list of included articles and of relevant 
reviews(28). Any web references will be archived before citation using WebCite ® technology 
(http://www.webcitation.org).  
 
Study selection 
After removal of duplicates, three independent reviewers (CL, GS, DV) screened titles and 
abstracts of all potentially eligible articles. Three authors applied the eligibility criteria, considered 
the full texts and a final list of included articles was reached through consensus. A fourth reviewer 
(BS) was available for mediation.   
 
Outcomes 
Our primary outcome of interest was the odds ratios (ORs) of the relative prevalence of 
smokers between ED participants (AN, BN, EDNOS, BED) and HCs. For the aim of this work, both 
lifetime and current smoking were considered, without any pre-specified threshold in the number of 
cigarettes or years of smoking. Secondarily, we investigated the prevalence of smokers in ED 
according to type of ED (AN, BN, EDNOS, BED).  We chose OR as outcome since the vast majority of 
studies have a cross-sectional design, making Relative Risk not appropriate. 
 
Data Extraction 
Two authors (NV, MS) independently extracted data using a predetermined extraction form, 
including: years of publication, country, setting, demographic characteristics for people with ED and 
the control groups (age, number of females, sample size, mean BMI values in each group), and if any 
matching criteria for age and sex were applied.  
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Quality assessment 
As previously suggested (29) for reporting the methodological quality of observational 
studies, the quality of the included studies was assessed descriptively through five items, i.e. 1) clear 
description of participants (eligibility, setting, and methods of participant selection); 2) reporting 
data on mean duration of disease and diagnostic criteria in people with ED ; 3) clear definition of 
smoking;  4) reporting data about body mass index (BMI) or other body composition parameters; 
and 5) use of matching approach between ED patients and controls.  
 
Meta-analysis 
Due to the anticipated heterogeneity, we utilized random effects meta-analysis and 
calculated odds ratios (ORs) and 95% confidence intervals (CIs) as the effect size measure with 
comprehensive meta-analysis (CMA, version 3).  The meta-analysis was conducted in the following 
steps. First, we calculated the OR statistic together with 95%CI to establish the difference in the 
proportion of smokers between each ED diagnostic group (AN, BN, EDNOS, BED) vs. HCs.  Second, 
we calculated the prevalence of smokers in each ED group.  Heterogeneity was assessed with the 
Cochrane Q and I2 statistics for each analysis (30). We conducted meta-regression analyses with CMA 
for outcomes with high heterogeneity (I2>50% and/or p<0.05) and reported by at least 4 studies to 
investigate potential moderators of the results among people with ED compared with HCs, including 
country, setting, criteria for diagnosis of ED (DSM-IV vs. others), use of matching criteria (yes vs. no), 
methods for assessing smoking history (structural interview vs. self-reported), sample size, mean 
age, BMI, percentage of females in the ED and HC sample. Also, differences in mean age, BMI and in 
percentage of females were tested as potential moderators of the heterogeneity. All analyses were 
conducted for lifetime smoking and, if available, for current smoking status. 
Publication bias was assessed with a visual inspection of funnel plots and with the Begg-Mazumdar 
Kendall's tau (31) and Egger bias test(32). In order to test for publication bias, we calculated the trim 
and fill adjusted analysis (33) to remove the most extreme small studies from the positive side of the 
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funnel plot, and recalculated the effect size at each iteration, until the funnel plot was symmetric 
about the (new) effect size.  Finally, we calculated the fail safe number of negative studies that 
would be required to nullify (i.e. make p>0.05) each of our comparative analyses(34). 
 
Search results 
The search identified 1,804 non-duplicated, potentially eligible studies. After excluding 1,711 
papers through title and abstract review, 93 full text articles were examined, leading to the inclusion 
of 31 eligible studies  in this meta-analysis (full details in Figure 1)(13,35–63). 
 
Characteristics of included studies and participants 
Study and patient characteristics are summarized in Table S1 (comparative meta-analysis 
studies) and Table S2 (prevalence studies (i.e., data from comparative and non-comparative 
studies)).The 31 studies included 76,852 participants (8,517 ED and 68,335 HCs). Of these, 2,033 
participants were diagnosed with AN (mean age: 24.4±6.1 years; mean BMI: 16.8±2.4), 2,620 with 
BN (mean age: 23.5±5.3 years; mean BMI: 22.9±4.1), 3,528 with BED (mean age: 26.2±5.8 years; 
mean BMI: 23.4±4.1), and 336 with EDNOS (mean age: 22.6±9.0 years; no studies with BMI data).  
The mean age of the 68,335 HCs was 26.7±4.5 years with a BMI of 23.0±3.1 Kg/m2. As reported in 
Tables S1-2, 13 studies used a structured interview for assessing smoking history, while the other 18 
utilized a self-reported questionnaire.  
Most studies were conducted in North America (18 studies), followed by 10 studies in 
Europe, and two in Oceania or Asia. All except six studies included only females and only five used 
matching criteria between ED and HCs. Full details of the included studies are reported in Tables S1-
2. 
 
Study reporting quality and risk of bias 
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Full details of study reporting quality are placed in Table S3, demonstrating that the most 
common sources of bias was the lack of matching between ED and HC and that several studies did 
not report data about BMI, other body composition parameters, and illness duration.  
 
 
 
Meta-analysis of smokers in ED and HCs 
As shown in Table 1, BN was associated with a significantly higher proportion of life-time 
smokers than HCs (OR=2.165; 95%CI: 1.642-2.855, p<0.0001; I2=88.2%; studies=10; 
(35,39,40,48,50,54,55,61,62,64)), without any evidence of publication bias (Begg=-0.13, p=0.59, 
Egger=0.98, p=0.67). People with BED were also significantly more likely to be life-time smokers than 
HC (OR=1.792; 95%CI: 1.228-2.616, p=0.002; I2=0%; studies=4; (40,54,59,60)).  
Conversely, in 7 studies(26,27,30,31,34,36,39 )there was no evidence that people with AN 
are more likely to smoke in any period of their life than HC (OR=0.927; 95%CI: 0.650-1.320, p=0.67; 
I2=70.4%).  There was no evidence of publication bias (Egger=-1.69, p=0.18, Begg=-0.09, p=0.76). 
Only one comparative study reported smoking status in EDNOS and found no significant difference 
compared to HCs (35).  
The trim and fill adjusted analyses remained unchanged for BN and BED.  The trim and fill 
analysis for comparative studies including AN yielded an adjusted and increased OR of 1.14 (95%CI: 
0.79-1.64), but the difference to HCs remained non-significant. 
We also compared current smoking prevalence in AN and BN vs. HCs. AN did not differ significantly 
regarding current smokers compared to HCs (OR=0.783; 95%CI: 0.45-1.34; p=0.31; studies=7), while 
BN had higher proportions of current smokers than HCs (OR=2.32; 95%CI: 1.12-4.78; p=0.02; 
studies=4) (Table 1). 
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Prevalence of smoking in ED 
Table 2 reports the prevalence of life-time and current smokers according to type of ED and 
other sub-group analyses, including publication bias data. Key findings are briefly summarised 
below. Among all ED, the highest prevalence of smokers was observed in BED (47.73%, 95%CI: 
34.80-60.97%; five studies; (40,54,59,65)), followed by BN (39.41%, 95%CI: 33.23-45.95%; 23 studies 
(35,37,39–41,44,46–52,54–57,61–64,66,67)), AN (22.45%, 95%CI: 17.07-28.95%; 16 studies (13,35–
47,49,67)) and EDNOS (22.17%, 95%CI: 10.51-40.85%; 2 studies (35,49)). We also calculated 
prevalence of current smokers in AN (21.6%; 95%CI: 15.6-29.1; studies=15),  in BN (36%; 95%CI: 
28.9-43.8; studies=17) and in EDNOS (14.8%, 95%CI 2.7-51.9, studies=2). 
Considering AN, setting, region in which the study was performed, and study type (with or without 
control group) did not affect the prevalence of life-time or current smokers. Conversely, BN studies 
conducted in Europe reported a significantly higher prevalence of life-time smokers (45.79%; 95%CI: 
35.05-56.93) compared with studies from other continents (p<0.001).  
Publication bias was evident for the main analyses in AN, and for studies conducted in North 
America among AN. After accounting for this issue, the trim and fill procedure suggested that the 
prevalence of life-time smokers was higher in AN in general (30.8%, 95%CI: 24.6-37.8%, 6 studies 
trimmed) as well as in the subgroup of North American studies (29.1%; 95%CI: 21.4-38.3%, 5 studies 
trimmed).  
 
Meta-regression of moderators of smokers in ED  
Meta-regression analyses for the prevalence of smokers in AN identified that a higher 
prevalence of smokers was moderated by  a higher mean age of participants (life-time smokers: 
=0.06; 95%CI: 0.01 to 0.11, p=0.02, R2=0.38; current smokers: =0.33; 95%CI: 0.08 to 0.59, p=0.01, 
R2=0.66 ) and a higher mean BMI (life-time smokers: =0.33; 95%CI: 0.00 to 0.63, p=0.03, R2=0.10).  
Regarding BN participants, the prevalence of life-time or current smokers was not 
moderated by either higher mean age, or mean BMI .  However, a higher proportion of females was 
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significantly associated with a higher prevalence of life-time smokers with BN (=0.05; 95%CI: 0.02 
to 0.09, p=0.005, R2=0.27). 
 
Discussion 
 The current meta-analysis of 31 studies demonstrated that people with BED and even more 
so with BN, but not those with AN, were significantly more likely to have a lifetime history of 
smoking than HCs.  Odds ratios indicated that BN and BED were around twice as likely to smoke as 
HCs.  Meta-analysis of prevalence rates demonstrated that almost half of BED smoked, and almost 
40% of the BN patients and 30% of people with AN smoked.  Meta-regression analyses identified 
that higher mean age and BMI moderate life-time smoking rates in AN, with higher age moderating 
also current smoking in people with AN, whereas a higher percentage of females moderated the 
prevalence of life-time smokers in BN. 
The high prevalence of smoking among BN could be due to the fact that smoking might be 
considered a compensatory behavior, since nicotine suppresses appetite, stimulates metabolism,  
and might control weight or modulate eating (19,68,69). Moreover smoking could be linked to both 
impulsive and compulsive personality traits and behaviors, which are known to be part of the 
relational and behavioral pattern in BN(70). Furthermore, smoking is associated with higher use of 
marijuana and alcohol(71), and different substance use is related in turn to increased incidence of 
attempted suicide, stealing, and sexual intercourse(42). Hence, much attention should be paid to the 
high smoking prevalence in patients with BN. However, among all ED, BED seem to have the highest 
presence of smokers. This is a concern, since these people are at increased risk of cardiovascular 
diseases due to higher presence of obesity(72), diabetes(73) and hypercholesterolemia(74). Hence, 
routine smoking assessment and smoking cessation treatment is warranted for those with BED and 
BN.  
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Conversely, our results suggest that AN is not associated with higher smoking frequencies 
than in HCs. Patients with AN likely pay  more attention to their ability to exercise and focus more on 
details (75), which may lead them to contemplate the health consequences of smoking more than 
other EDs. However, as suggested by our meta-regression analysis, it should be noted that in AN 
higher BMI moderated higher prevalence of smokers, suggesting that also in this ED, tobacco 
smoking might be being used as compensatory behavior to lose weight.  Unfortunately, among AN, 
uptake of outpatient services related to concerns about their health are poor, which would be an 
opportunity to explain the potential risks associated  with cigarette use and initiate smoking 
cessation interventions (76).However, there is evidence that smoking cessation may exacerbate AN 
symptoms, and eating behavior should be carefully monitored in patients with lifetime AN who are 
attempting to quit smoking(77). Finally, the lower smoking prevalence in AN could also be due to a 
reporting bias in that patients with AN may be more likely to underreport unhealthy behaviors, 
similarly as for other self-reported information(78). Further studies should clarify smoking frequency 
in AN compared with HCs. 
Considering the high prevalence of tobacco use in ED, in particular in patients with BN and 
BED, and in light of previous evidence suggesting that smoking is associated with alcohol abuse, 
poorer physical quality of life, increased risk of metabolic syndrome and cardiovascular risk factors, 
alongside with depressive symptoms in BED (79,80); clinicians should ask people with ED about their 
smoking status, and provide appropriate counseling and interventions (81).  
Whilst our meta-analysis is the first to comprehensively assess smoking prevalence’s in 
people with different kind of EDs, the findings should be considered within the study’s limitations. 
First, we were not able to meta-analyze more detailed quantitative data (e.g. number of cigarettes, 
duration of smoking etc.) about smoking in patients with ED. Such data would have been relevant 
since several medical conditions (like cancer) show a dose-response with the number of cigarettes 
smoked. Further, nor did we have data on current smoking rates, especially not confirmed with 
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biochemical measures, such as expired carbon monoxide or cotinine. Second, we were not able to 
distinguish restrictive AN (RAN) from binge-purge AN (BPAN). This is an important limitation, since 
from a clinical and impulsivity-related perspective patients with BPAN are closer to BN than RAN, 
Therefore, smoking status in these two subgroups should be compared in future studies. Third, most 
of the meta-analyzed studies included females, and it remains unclear if the same results are evident 
in males with ED. However, our meta-regression analysis suggests that being female was at least 
related to a higher prevalence of smokers in BN. Further studies including males in ED are warranted 
to better clarify a potential effect of sex. Fourth, in several studies BMI or other relevant 
anthropometric measures were not reported. The effect of smoking on adiposity in ED remains to be 
confirmed with better designed studies. Finally, another potential bias could be due to the lack of 
matching between ED and HCs in most studies. On the other hand, notable strengths of this meta-
analysis, besides it being the first on this important topic, are: (a) the large number of included 
studies (n=31) and(b) the large sample size (over 70,000 participants). 
In conclusion, smoking is highly prevalent in ED, in particular among people with BED and 
BN.  Further, high-quality studies are needed to assess the time course of ED and smoking, the 
impact of smoking on the onset and development of medical complications in eating disorders, and, 
most importantly, the effectiveness of interventions aimed at promoting smoking cessation in 
people with ED. 
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Table 1: Meta-analysis of smoking rates in patients with eating disorders versus controls 
 
 
 
Key: SMD = standardised mean difference, CI = confidence interval, EDNOS= eating disorder not 
otherwise specified, BED= binge eating disorder 
 
 
 
 
 
Analysis Number 
of 
studies 
Number 
participants 
Meta-analysis Heterogeneity Publication bias 
  ED HC OR 95% CI P value I2 Egger 
bias & 
p 
value 
Trim and 
fill (95% 
CI)  
[NR 
studies 
trimmed] 
Life-
time 
Smokers 
          
Anorexia 
Nervosa 
7 1617 1350 0.93 0.65 1.32 0.674 70.4 -1.69, 
p=0.18 
1.14 (0.79 
to 1.64) [2] 
Bulimia 
Nervosa 
10 149 139 2.16 1.64 2.85 <0.0001 88.2 0.98, 
p=0.67 
Unchanged 
BED 4 3425 4313 1.79 1.23 2.62 0.002 0 0.90, 
p=0.31 
Unchanged 
Current 
Smokers 
          
Anorexia 
Nervosa 
7 578 2131 0.78 0.45 1.34 0.31 83.3 -1.02, 
p=0.27 
Unchanged 
Bulimia 
Nervosa 
4 322 592 2.32 1.12 4.78 0.02 61.3 0.67, 
p=0.71 
Unchanged 
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Table 2.Life-time and current prevalence of smokers in each eating disorder subcategory 
 
Analysis Numbe
r of 
studies 
Number 
participant
s 
Meta-analysis Heterogeneit
y 
Publication bias 
  ED Prevalenc
e 
95% CI 
 
I2 Egger 
bias & 
p 
value 
Trim and 
fill (95% 
CI) 
[Number 
studies 
trimmed] 
LIFE-TIME SMOKERS 
Anorexi
a 
Nervosa 
16 2033 22.45 17.0
7 
 
28.9
5 
84.9 -2.8, 
p<0.0
5 
30.8 (24.6 
to 37.8) 
[6] 
Bulimia 
Nervosa 
23 2620 39.41 33.2
3 
 
45.9
5 
89.2 -1.6, 
p=0.2
7 
unchange
d 
EDNOS 2 336 22.17 10.5
1 
 
40.8
5 
97.5 N/A N/A 
BED 5 3528 47.73 34.8
0 
 
60.9
7 
96.9 -5.6, 
p=0.2
6 
56.2 (44.2 
to 67.6) 
[2] 
CURRENT SMOKERS 
Anorexi
a 
Nervosa 
15 1168 21.6 15.6 
 
29.1 89.7 -1.1, 
p-0.45 
Unchange
d 
Bulimia 
Nervosa 
17 1557 36.04 28.9 
 
43.8 86.6 0.78, 
p=0.6
1 
Unchange
d 
EDNOS 2 304 14.8 2.7 
 
51.9 92.7 N/A N/A 
  
This article is protected by copyright. All rights reserved. 
 
Figure 1.  PRISMA flow-chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Key: ED= Eating Disorders 
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